Allspring Global Investments
ASTH icon

Allspring Global Investments’s Astrana Health ASTH Stock Holding History

Allspring Global Investments’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-74
Closed -$3K – 2613
2024
Q2 		$3K Buy
+74
New +$2.94K ﹤0.01% 2261
2023
Q4 		– Sell
-920
Closed -$28.4K – 2783
2023
Q3 		$28.4K Sell
920
-1,346
-59% -$46.4K ﹤0.01% 2430
2023
Q2 		$71.6K Sell
2,266
-42
-2% -$1.44K ﹤0.01% 2175
2023
Q1 		$84.2K Sell
2,308
-314
-12% -$11K ﹤0.01% 2108
2022
Q4 		$77.6K Sell
2,622
-2,112
-45% -$67.9K ﹤0.01% 2171
2022
Q3 		$184K Sell
4,734
-1,701
-26% -$77.9K ﹤0.01% 1848
2022
Q2 		$248K Sell
6,435
-17,777
-73% -$676K ﹤0.01% 1756
2022
Q1 		$1.17M Buy
24,212
+2,832
+13% +$146K ﹤0.01% 1789
2021
Q4 		$1.57M Buy
+21,380
New +$1.76M ﹤0.01% 1673

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Allspring Global Investments's ASTH Position: Q3 2024 in Review

Allspring Global Investments sold out of Astrana Health (ASTH) in Q3 2024, closing a stake of 74 shares — an estimated $3K sold.

Allspring Global Investments first reported a position in ASTH in Q4 2021 and held it in 9 quarters. The position peaked at $1.57M in Q4 2021. 189 funds tracked by Wall St. Rank hold ASTH as of Q3 2024.

  • Allspring Global Investments reported no remaining Astrana Health position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 74 Astrana Health shares in Q3 2024, an estimated $3K.
  • Allspring Global Investments first reported a position in Astrana Health in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Astrana Health position peaked at $1.57M in Q4 2021.
  • 189 funds tracked by Wall St. Rank held Astrana Health as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.